Zobrazeno 1 - 10
of 1 080
pro vyhledávání: '"G, Engelhardt"'
Autor:
Inge S van Strien-Knippenberg, Daniëlle R M Timmermans, Ellen G Engelhardt, Inge R H M Konings, Olga C Damman
Publikováno v:
PLoS ONE, Vol 19, Iss 9, p e0309668 (2024)
BackgroundIf communicated adequately, numerical decision-relevant information can support informed and shared decision making. Visual formats are recommended, but which format supports patients depending on their health literacy (HL) levels for speci
Externí odkaz:
https://doaj.org/article/0c42c57ee5f645e2815ee71c07419628
Autor:
Cornelis Verhoef, Rick L Haas, Elske M van den Akker-van Marle, Leti van Bodegom-Vos, Michiel A J van de Sande, Ellen G Engelhardt, Perla Marang-van de Mheen, Anouk A Kruiswijk, Yvonne M Schrage, Robert J van Ginkel, Han Bonenkamp, Marc HA Bemelmans, Ibtissam Acem, Stefanie Hakkesteegt, Roos F Bleckman, Marloes van Duijvenbode, Nicolette Leijerzapf, Jos A van der Hage, Robert J.P. van der Wal
Publikováno v:
BMJ Open, Vol 13, Iss 11 (2023)
Introduction Current treatment decision-making in high-grade soft-tissue sarcoma (STS) care is not informed by individualised risks for different treatment options and patients’ preferences. Risk prediction tools may provide patients and profession
Externí odkaz:
https://doaj.org/article/1bc6e7a42b9748709211f848ccf38441
Publikováno v:
BMC Medical Research Methodology, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background Clinical prediction models are often not evaluated properly in specific settings or updated, for instance, with information from new markers. These key steps are needed such that models are fit for purpose and remain relevant in t
Externí odkaz:
https://doaj.org/article/e2d1d4e33e7a4a12b923e6b1df3ba73c
Autor:
Petra Mooij, Daniella Mortier, Aafke Aartse, Alexandre B. Murad, Ricardo Correia, António Roldão, Paula M. Alves, Zahra Fagrouch, Dirk Eggink, Norbert Stockhofe, Othmar G. Engelhardt, Ernst J. Verschoor, Marit J. van Gils, Willy M. Bogers, Manuel J. T. Carrondo, Edmond J. Remarque, Gerrit Koopman
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
The first exposure to influenza is presumed to shape the B-cell antibody repertoire, leading to preferential enhancement of the initially formed responses during subsequent exposure to viral variants. Here, we investigated whether this principle rema
Externí odkaz:
https://doaj.org/article/fe0da1bcfd6c40f6beed32ab73a26fdd
Autor:
Joanna Waldock, Edmond J. Remarque, Lingyi Zheng, Sammy Ho, Katja Hoschler, Britta Neumann, Hanna Sediri-Schön, Claudia M. Trombetta, Emanuele Montomoli, Serena Marchi, Giulia Lapini, Fan Zhou, Sarah L. Lartey, Rebecca J. Cox, Marzia Facchini, Maria Rita Castrucci, Damien Friel, Thierry Ollinger, Catherine Caillet, Nedzad Music, Giuseppe Palladino, Othmar G. Engelhardt, the FLUCOP consortium
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionThe haemagglutination inhibition assay (HAI) and the virus microneutralisation assay (MN) are long-established methods for quantifying antibodies against influenza viruses. Despite their widespread use, both assays require standardisation
Externí odkaz:
https://doaj.org/article/629a9a87d5334e42a64da525e3563416
Autor:
Joanna Waldock, Carol D. Weiss, Wei Wang, Min Z. Levine, Stacie N. Jefferson, Sammy Ho, Katja Hoschler, Brandon Z. Londt, Elisa Masat, Louise Carolan, Stephany Sánchez-Ovando, Annette Fox, Shinji Watanabe, Miki Akimoto, Aya Sato, Noriko Kishida, Amelia Buys, Lorens Maake, Cardia Fourie, Catherine Caillet, Sandrine Raynaud, Richard J. Webby, Jennifer DeBeauchamp, Rebecca J. Cox, Sarah L. Lartey, Claudia M. Trombetta, Serena Marchi, Emanuele Montomoli, Iván Sanz-Muñoz, José María Eiros, Javier Sánchez-Martínez, Danny Duijsings, Othmar G. Engelhardt
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionExternal Quality Assessment (EQA) schemes are designed to provide a snapshot of laboratory proficiency, identifying issues and providing feedback to improve laboratory performance and inter-laboratory agreement in testing. Currently there
Externí odkaz:
https://doaj.org/article/336faf037fe6487d9afa1b75516f9b2d
Autor:
Tiziano Gaiotto, Walter Ramage, Christina Ball, Paul Risley, George W. Carnell, Nigel Temperton, Othmar G. Engelhardt, Simon E. Hufton
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract Influenza H7N9 virus continues to cause infections in humans and represents a significant pandemic risk. During the most recent 5th epidemic wave in 2016/17 two distinct lineages with increased human infections and wider geographical spread
Externí odkaz:
https://doaj.org/article/204a4bf957ea4639994ee314f4ba3f3d
Autor:
Marie-Clotilde Bernard, Joanna Waldock, Sylvie Commandeur, Lea Strauß, Claudia Maria Trombetta, Serena Marchi, Fan Zhou, Serge van de Witte, Peter van Amsterdam, Sammy Ho, Katja Hoschler, Vladimir Lugovtsev, Jerry P. Weir, Emanuele Montomoli, Rebecca J. Cox, Othmar G. Engelhardt, Damien Friel, Ralf Wagner, Thierry Ollinger, Sophie Germain, Hanna Sediri-Schön
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Current vaccination strategies against influenza focus on generating an antibody response against the viral haemagglutination surface protein, however there is increasing interest in neuraminidase (NA) as a target for vaccine development. A critical
Externí odkaz:
https://doaj.org/article/c7eb7830935240038d837eec99dca889
Autor:
Brendan L. Mangan, Dilan Patel, Heidi Chen, Katie S. Gatwood, Michael T. Byrne, Salyka Sengsayadeth, Stacey Goodman, Bhagirathbhai Dholaria, Adetola A. Kassim, Madan Jagasia, Wichai Chinratanalab, Kathryn A. Culos, Brian G. Engelhardt
Publikováno v:
eJHaem, Vol 1, Iss 2, Pp 576-580 (2020)
Abstract Haploidentical hematopoietic cell transplantation (haplo‐HCT) with posttransplant cyclophosphamide (PTCY) is utilized for patients with hematological disorders but without conventional donors. The effects of new‐onset posttransplant diab
Externí odkaz:
https://doaj.org/article/c10492381e0a4e2f84e708a1430bb2ac
Autor:
Sena Alaeikhanehshir, Ellen G. Engelhardt, Frederieke H. van Duijnhoven, Maartje van Seijen, Patrick A. Bhairosing, Donna Pinto, Deborah Collyar, Elinor Sawyer, Shelley E. Hwang, Alastair M. Thompson, Jelle Wesseling, Esther H. Lips, Marjanka K. Schmidt
Publikováno v:
Breast, Vol 50, Iss , Pp 95-103 (2020)
Objective: The majority of ‘low-risk’ (grade I/II) Ductal Carcinoma In Situ (DCIS) may not progress to invasive breast cancer during a women’s lifetime. Therefore, the safety of active surveillance versus standard surgical treatment for DCIS is
Externí odkaz:
https://doaj.org/article/b800c69886634c58ac9c9fedd17ea552